<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/" version="2.0">
  <channel>
    <title>Case study</title>
    <link>https://246164334.hs-sites-na2.com/case-study</link>
    <description>Genomebeans Case study</description>
    <language>en-us</language>
    <pubDate>Mon, 20 Jul 2026 10:54:37 GMT</pubDate>
    <dc:date>2026-07-20T10:54:37Z</dc:date>
    <dc:language>en-us</dc:language>
    <item>
      <title>Cutting a Singleton Variant List From Thousands to a Shortlist Using Trio Whole-Exome Sequencing</title>
      <link>https://246164334.hs-sites-na2.com/case-study/cutting-a-singleton-variant-list-from-thousands-to-a-shortlist-using-trio-whole-exome-sequencing</link>
      <description>&lt;div class="hs-featured-image-wrapper"&gt; 
 &lt;a href="https://246164334.hs-sites-na2.com/case-study/cutting-a-singleton-variant-list-from-thousands-to-a-shortlist-using-trio-whole-exome-sequencing" title="" class="hs-featured-image-link"&gt; &lt;img src="https://246164334.hs-sites-na2.com/hubfs/From%20Tumor%20Tissue%20to%20a%20Tiered-1.png" alt="Cutting a Singleton Variant List From Thousands to a Shortlist Using Trio Whole-Exome Sequencing" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"&gt; &lt;/a&gt; 
&lt;/div&gt;   
&lt;h2&gt;Singleton exomes leave the hardest question unanswered&lt;/h2&gt; 
&lt;p&gt;A standard singleton whole-exome analysis can call tens of thousands of variants, and even aggressive population-frequency and ACMG-based filtering typically leaves several hundred candidates per case. Without a second and third genome to compare against — the parents' — a geneticist has no automated way to tell which of those candidates arose spontaneously in the proband and which were simply inherited from an unaffected parent. That distinction is often the difference between a shortlist a clinician can review in an afternoon and one they can't.&lt;/p&gt;</description>
      <content:encoded>&lt;div class="hs-featured-image-wrapper"&gt; 
 &lt;a href="https://246164334.hs-sites-na2.com/case-study/cutting-a-singleton-variant-list-from-thousands-to-a-shortlist-using-trio-whole-exome-sequencing" title="" class="hs-featured-image-link"&gt; &lt;img src="https://246164334.hs-sites-na2.com/hubfs/From%20Tumor%20Tissue%20to%20a%20Tiered-1.png" alt="Cutting a Singleton Variant List From Thousands to a Shortlist Using Trio Whole-Exome Sequencing" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"&gt; &lt;/a&gt; 
&lt;/div&gt;   
&lt;h2&gt;Singleton exomes leave the hardest question unanswered&lt;/h2&gt; 
&lt;p&gt;A standard singleton whole-exome analysis can call tens of thousands of variants, and even aggressive population-frequency and ACMG-based filtering typically leaves several hundred candidates per case. Without a second and third genome to compare against — the parents' — a geneticist has no automated way to tell which of those candidates arose spontaneously in the proband and which were simply inherited from an unaffected parent. That distinction is often the difference between a shortlist a clinician can review in an afternoon and one they can't.&lt;/p&gt;    
&lt;img src="https://track-na2.hubspot.com/__ptq.gif?a=246164334&amp;amp;k=14&amp;amp;r=https%3A%2F%2F246164334.hs-sites-na2.com%2Fcase-study%2Fcutting-a-singleton-variant-list-from-thousands-to-a-shortlist-using-trio-whole-exome-sequencing&amp;amp;bu=https%253A%252F%252F246164334.hs-sites-na2.com%252Fcase-study&amp;amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "&gt;</content:encoded>
      <category>Case Study</category>
      <pubDate>Thu, 16 Jul 2026 13:52:00 GMT</pubDate>
      <guid>https://246164334.hs-sites-na2.com/case-study/cutting-a-singleton-variant-list-from-thousands-to-a-shortlist-using-trio-whole-exome-sequencing</guid>
      <dc:date>2026-07-16T13:52:00Z</dc:date>
      <dc:creator>Genomebeans Team</dc:creator>
    </item>
    <item>
      <title>Screening 40 Camel Blood Samples for Hidden Pathogens with Shotgun Metagenomics</title>
      <link>https://246164334.hs-sites-na2.com/case-study/from-tumor-tissue-to-a-tiered-therapy-matched-variant-report-in-non-small-cell-lung-cancer</link>
      <description>&lt;div class="hs-featured-image-wrapper"&gt; 
 &lt;a href="https://246164334.hs-sites-na2.com/case-study/from-tumor-tissue-to-a-tiered-therapy-matched-variant-report-in-non-small-cell-lung-cancer" title="" class="hs-featured-image-link"&gt; &lt;img src="https://246164334.hs-sites-na2.com/hubfs/Oncology%20Labs%20Are%20Missing%20Actionable%20Tumor%20Mutations-1.png" alt="Screening 40 Camel Blood Samples for Hidden Pathogens with Shotgun Metagenomics" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"&gt; &lt;/a&gt; 
&lt;/div&gt;   
&lt;h2&gt;From "something might be wrong" to a validated candidate list&lt;/h2&gt; 
&lt;p&gt;Veterinary teams increasingly turn to sequencing when culture and PCR panels come back inconclusive — a common situation in camelid medicine, where circulating pathogens are less characterized than in cattle or small ruminants. This client's finance and diagnostics teams had already validated Illumina-based sequencing for other applications; the open question was whether a metagenomic pipeline could reliably tell them&lt;em&gt;what&lt;/em&gt;, if anything, was present in blood, without prior assumptions about the organism.&lt;/p&gt;   
&lt;h3&gt;About the Study&lt;/h3&gt; 
&lt;p&gt;&lt;span style="color: #516674; background-color: #ffffff;"&gt;A camelid health program spanning multiple herd sites ran a 40-sample pilot to evaluate shotgun metagenomics as a routine diagnostic screening tool. The objective: detect any bacteria, fungi, viruses, or parasites present in blood that could plausibly explain clinical signs of infection, using an approach sensitive enough to catch low-abundance or atypical organisms that targeted panels would miss.&lt;/span&gt;&lt;/p&gt; 
&lt;p&gt;&amp;nbsp;&lt;/p&gt; 
&lt;h2&gt;The Challenge&lt;/h2&gt;  
&lt;h3&gt;Blood is a low-biomass, high-noise sample type&lt;/h3&gt; 
&lt;p&gt;Unlike gut or environmental metagenomics, blood carries very little non-host DNA — the overwhelming majority of reads come from the camel genome itself. That creates two compounding problems for pathogen detection:&lt;/p&gt; 
&lt;ul&gt; 
 &lt;li&gt;Host DNA has to be removed thoroughly and correctly, or it drowns out the microbial signal and inflates compute cost for downstream steps.&lt;/li&gt; 
 &lt;li&gt;Whatever pathogen signal remains is often sparse, which makes it easy to either miss a real low-abundance organism or over-call background/contaminant reads as a hit.&lt;/li&gt; 
&lt;/ul&gt; 
&lt;p&gt;The client's brief reflected this directly: since a well-annotated&lt;em&gt;Camelus dromedarius&lt;/em&gt;reference genome was already available, they wanted host removal handled by direct alignment to that reference rather than any assembly-based step — and wanted the resulting taxonomic calls held to a clear confidence and coverage threshold before anything was reported as a candidate pathogen.&lt;/p&gt; 
&lt;p&gt;&lt;span style="color: #112b4a; font-size: 28px; font-weight: 800; text-align: var(--bs-body-text-align);"&gt;The GenomeBeans Approach&lt;/span&gt;&lt;/p&gt; 
&lt;p&gt;&lt;span style="text-align: var(--bs-body-text-align);"&gt;GenomeBeans' metagenomics pipeline was configured around the client's existing reference genome rather than a de novo step. For this cohort, the workflow ran as follows:&lt;/span&gt;&lt;/p&gt;  
&lt;ol&gt; 
 &lt;li&gt; &lt;h4&gt;Quality control and trimming&lt;/h4&gt; &lt;/li&gt; 
&lt;/ol&gt; 
&lt;p&gt;Raw FASTQ files from each of the 40 samples (~50M read pairs each) were assessed for base quality, adapter content, duplication rate, and GC distribution before any filtering, so early anomalies in a specific sample could be flagged rather than silently propagated downstream. &lt;br&gt;&lt;code&gt;&lt;span style="color: #12324a; background-color: #e4f4f0;"&gt;read QC + adapter/quality trimming&lt;/span&gt;&lt;/code&gt;&lt;span style="color: #112b4a;"&gt;&lt;br&gt;&lt;/span&gt;&lt;/p&gt; 
&lt;h4&gt;&lt;br&gt;Dehosting against the camel reference genome&lt;/h4&gt; 
&lt;p&gt;Trimmed reads were aligned to the&lt;em&gt;Camelus dromedarius&lt;/em&gt;reference assembly, and any read mapping to host sequence was removed. For a blood sample, this step typically strips the large majority of total reads — it's the difference between a microbial signal that's detectable and one that's statistically invisible.&lt;br&gt;&lt;code&gt;&lt;span style="color: #12324a; background-color: #e4f4f0;"&gt;reference-based host subtraction&lt;/span&gt;&lt;/code&gt;&lt;code&gt;&lt;br&gt;&lt;/code&gt;&lt;/p&gt; 
&lt;h4&gt;Deduplication&lt;/h4&gt; 
&lt;p&gt;PCR and optical duplicates introduced during library prep were removed from the dehosted read set, correcting for the abundance inflation and false-negative risk they cause in small, low-biomass libraries.&lt;/p&gt; 
&lt;h4&gt;Taxonomic classification &amp;amp; abundance profiling&lt;/h4&gt; 
&lt;p&gt;Dehosted, deduplicated reads were classified directly against curated bacterial, fungal, viral, and parasitic reference databases, generating a relative abundance profile of every taxon detected in each sample. Working from the client's own reference genome for dehosting meant this step could run straight off clean, host-free reads rather than waiting on an assembly step.&lt;br&gt;&lt;code&gt;&lt;span style="color: #12324a; background-color: #e4f4f0;"&gt;database-driven taxonomic classification&lt;/span&gt;&lt;/code&gt;&lt;/p&gt; 
&lt;h4&gt;Confidence and coverage validation&lt;/h4&gt; 
&lt;p&gt;Every taxonomic call was checked against minimum read-depth and classification-confidence thresholds before being added to the candidate list, filtering out low-support hits that commonly turn up as background or lab contaminants in low-biomass blood samples. Only calls that cleared both thresholds were carried into the client's final report.&lt;br&gt;&lt;code&gt;&lt;span style="color: #12324a; background-color: #e4f4f0;"&gt;threshold-based call filtering&lt;/span&gt;&lt;/code&gt;&lt;/p&gt; 
&lt;p&gt;&lt;code&gt;&lt;/code&gt;&lt;/p&gt; 
&lt;div&gt; 
 &lt;h4&gt;&amp;nbsp;&lt;/h4&gt; 
&lt;/div&gt;</description>
      <content:encoded>&lt;div class="hs-featured-image-wrapper"&gt; 
 &lt;a href="https://246164334.hs-sites-na2.com/case-study/from-tumor-tissue-to-a-tiered-therapy-matched-variant-report-in-non-small-cell-lung-cancer" title="" class="hs-featured-image-link"&gt; &lt;img src="https://246164334.hs-sites-na2.com/hubfs/Oncology%20Labs%20Are%20Missing%20Actionable%20Tumor%20Mutations-1.png" alt="Screening 40 Camel Blood Samples for Hidden Pathogens with Shotgun Metagenomics" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"&gt; &lt;/a&gt; 
&lt;/div&gt;   
&lt;h2&gt;From "something might be wrong" to a validated candidate list&lt;/h2&gt; 
&lt;p&gt;Veterinary teams increasingly turn to sequencing when culture and PCR panels come back inconclusive — a common situation in camelid medicine, where circulating pathogens are less characterized than in cattle or small ruminants. This client's finance and diagnostics teams had already validated Illumina-based sequencing for other applications; the open question was whether a metagenomic pipeline could reliably tell them&lt;em&gt;what&lt;/em&gt;, if anything, was present in blood, without prior assumptions about the organism.&lt;/p&gt;   
&lt;h3&gt;About the Study&lt;/h3&gt; 
&lt;p&gt;&lt;span style="color: #516674; background-color: #ffffff;"&gt;A camelid health program spanning multiple herd sites ran a 40-sample pilot to evaluate shotgun metagenomics as a routine diagnostic screening tool. The objective: detect any bacteria, fungi, viruses, or parasites present in blood that could plausibly explain clinical signs of infection, using an approach sensitive enough to catch low-abundance or atypical organisms that targeted panels would miss.&lt;/span&gt;&lt;/p&gt; 
&lt;p&gt;&amp;nbsp;&lt;/p&gt; 
&lt;h2&gt;The Challenge&lt;/h2&gt;  
&lt;h3&gt;Blood is a low-biomass, high-noise sample type&lt;/h3&gt; 
&lt;p&gt;Unlike gut or environmental metagenomics, blood carries very little non-host DNA — the overwhelming majority of reads come from the camel genome itself. That creates two compounding problems for pathogen detection:&lt;/p&gt; 
&lt;ul&gt; 
 &lt;li&gt;Host DNA has to be removed thoroughly and correctly, or it drowns out the microbial signal and inflates compute cost for downstream steps.&lt;/li&gt; 
 &lt;li&gt;Whatever pathogen signal remains is often sparse, which makes it easy to either miss a real low-abundance organism or over-call background/contaminant reads as a hit.&lt;/li&gt; 
&lt;/ul&gt; 
&lt;p&gt;The client's brief reflected this directly: since a well-annotated&lt;em&gt;Camelus dromedarius&lt;/em&gt;reference genome was already available, they wanted host removal handled by direct alignment to that reference rather than any assembly-based step — and wanted the resulting taxonomic calls held to a clear confidence and coverage threshold before anything was reported as a candidate pathogen.&lt;/p&gt; 
&lt;p&gt;&lt;span style="color: #112b4a; font-size: 28px; font-weight: 800; text-align: var(--bs-body-text-align);"&gt;The GenomeBeans Approach&lt;/span&gt;&lt;/p&gt; 
&lt;p&gt;&lt;span style="text-align: var(--bs-body-text-align);"&gt;GenomeBeans' metagenomics pipeline was configured around the client's existing reference genome rather than a de novo step. For this cohort, the workflow ran as follows:&lt;/span&gt;&lt;/p&gt;  
&lt;ol&gt; 
 &lt;li&gt; &lt;h4&gt;Quality control and trimming&lt;/h4&gt; &lt;/li&gt; 
&lt;/ol&gt; 
&lt;p&gt;Raw FASTQ files from each of the 40 samples (~50M read pairs each) were assessed for base quality, adapter content, duplication rate, and GC distribution before any filtering, so early anomalies in a specific sample could be flagged rather than silently propagated downstream. &lt;br&gt;&lt;code&gt;&lt;span style="color: #12324a; background-color: #e4f4f0;"&gt;read QC + adapter/quality trimming&lt;/span&gt;&lt;/code&gt;&lt;span style="color: #112b4a;"&gt;&lt;br&gt;&lt;/span&gt;&lt;/p&gt; 
&lt;h4&gt;&lt;br&gt;Dehosting against the camel reference genome&lt;/h4&gt; 
&lt;p&gt;Trimmed reads were aligned to the&lt;em&gt;Camelus dromedarius&lt;/em&gt;reference assembly, and any read mapping to host sequence was removed. For a blood sample, this step typically strips the large majority of total reads — it's the difference between a microbial signal that's detectable and one that's statistically invisible.&lt;br&gt;&lt;code&gt;&lt;span style="color: #12324a; background-color: #e4f4f0;"&gt;reference-based host subtraction&lt;/span&gt;&lt;/code&gt;&lt;code&gt;&lt;br&gt;&lt;/code&gt;&lt;/p&gt; 
&lt;h4&gt;Deduplication&lt;/h4&gt; 
&lt;p&gt;PCR and optical duplicates introduced during library prep were removed from the dehosted read set, correcting for the abundance inflation and false-negative risk they cause in small, low-biomass libraries.&lt;/p&gt; 
&lt;h4&gt;Taxonomic classification &amp;amp; abundance profiling&lt;/h4&gt; 
&lt;p&gt;Dehosted, deduplicated reads were classified directly against curated bacterial, fungal, viral, and parasitic reference databases, generating a relative abundance profile of every taxon detected in each sample. Working from the client's own reference genome for dehosting meant this step could run straight off clean, host-free reads rather than waiting on an assembly step.&lt;br&gt;&lt;code&gt;&lt;span style="color: #12324a; background-color: #e4f4f0;"&gt;database-driven taxonomic classification&lt;/span&gt;&lt;/code&gt;&lt;/p&gt; 
&lt;h4&gt;Confidence and coverage validation&lt;/h4&gt; 
&lt;p&gt;Every taxonomic call was checked against minimum read-depth and classification-confidence thresholds before being added to the candidate list, filtering out low-support hits that commonly turn up as background or lab contaminants in low-biomass blood samples. Only calls that cleared both thresholds were carried into the client's final report.&lt;br&gt;&lt;code&gt;&lt;span style="color: #12324a; background-color: #e4f4f0;"&gt;threshold-based call filtering&lt;/span&gt;&lt;/code&gt;&lt;/p&gt; 
&lt;p&gt;&lt;code&gt;&lt;/code&gt;&lt;/p&gt; 
&lt;div&gt; 
 &lt;h4&gt;&amp;nbsp;&lt;/h4&gt; 
&lt;/div&gt;  
&lt;img src="https://track-na2.hubspot.com/__ptq.gif?a=246164334&amp;amp;k=14&amp;amp;r=https%3A%2F%2F246164334.hs-sites-na2.com%2Fcase-study%2Ffrom-tumor-tissue-to-a-tiered-therapy-matched-variant-report-in-non-small-cell-lung-cancer&amp;amp;bu=https%253A%252F%252F246164334.hs-sites-na2.com%252Fcase-study&amp;amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "&gt;</content:encoded>
      <category>Case Study</category>
      <pubDate>Tue, 14 Jul 2026 07:51:03 GMT</pubDate>
      <guid>https://246164334.hs-sites-na2.com/case-study/from-tumor-tissue-to-a-tiered-therapy-matched-variant-report-in-non-small-cell-lung-cancer</guid>
      <dc:date>2026-07-14T07:51:03Z</dc:date>
      <dc:creator>Genomebeans Team</dc:creator>
    </item>
  </channel>
</rss>
